This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Document and Entity Information
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Changes in Stockholders' Deficit
Consolidated Statements of Cash Flows
Notes to Financial Statements
Company Overview and Equity Transactions
Basis of Presentation and Principles of Consolidation
Summary of Significant Accounting Policies
Risks and Uncertainties
Revenues and Trade Receivables, Net
Material Agreements
Inventory
Property and Equipment, Net
Right-of-Use Assets and Lease Obligations
Intangible Assets, Net and Other non-current assets
Accrued Expenses
12.5% Senior Secured Notes and Loans Payable
Warrants
Sale of Future Revenue
Other Non-Current Liabilities
Net Loss Per Share
Share-Based Compensation
Employee Benefit Plans
Income Taxes
Contingencies
Quarterly Financial Data (unaudited)
Subsequent Events
Accounting Policies
Basis of Presentation and Principles of Consolidation (Policies)
Summary of Significant Accounting Policies (Policies)
Notes Tables
Revenues and Trade Receivables, Net (Tables)
Inventory (Tables)
Property and Equipment, Net (Tables)
Right-of-Use Assets and Lease Obligations (Tables)
Intangible Assets, Net and Other non-current assets (Tables)
Accrued Expenses (Tables)
12.5% Senior Secured Notes and Loans Payable (Tables)
Sale of Future Revenue (Tables)
Other Non-Current Liabilities (Tables)
Net Loss Per Share (Tables)
Share-Based Compensation (Tables)
Income Taxes (Tables)
Quarterly Financial Data (unaudited) (Tables)
Notes Details
Company Overview and Equity Transactions (Details)
Summary of Significant Accounting Policies, Concentration of Credit Risk (Details)
Summary of Significant Accounting Policies, Trade Accounts Receivable (Details)
Summary of Significant Accounting Policies, Revenue Recognition (Details)
Summary of Significant Accounting Policies, Fair Value Measurements (Details)
Summary of Significant Accounting Policies, Deferred Offering Costs and Recent Accounting Pronouncements (Details)
Risks and Uncertainties (Details)
Revenues and Trade Receivables, Net, Revenue (Details)
Revenues and Trade Receivables, Net, Disaggregation of Revenue (Details)
Revenues and Trade Receivables, Net, Accounts Receivable, Net (Details)
Revenues and Trade Receivables, Net, Changes in Allowance for Bad Debt (Details)
Revenues and Trade Receivables, Net, Changes in Sales-Related Allowances (Details)
Revenues and Trade Receivables, Net, Concentration of Major Customers (Details)
Material Agreements, Agreement with Indivior (Details)
Material Agreements, License Agreement with Sunovion Pharmaceuticals (Details)
Material Agreements, Purchase and Sale Agreement with an Affiliate of Marathon Asset Management (Details)
Material Agreements, Agreement to Terminate CLA with KemPharm (Details)
Inventory (Details)
Property and Equipment, Net (Details)
Right-of-Use Assets and Lease Obligations (Details)
Intangible Assets, Net and Other non-current assets (Details)
Accrued Expenses (Details)
12.5% Senior Secured Notes and Loans Payable (Details)
12.5 % Senior Secured Notes and Loans Payable, Perceptive (Details)
Warrants (Details)
Sale of Future Revenue (Details)
Other Non-Current Liabilities (Details)
Net Loss Per Share (Details)
Share-Based Compensation (Details)
Employee Benefit Plans (Details)
Income Taxes (Details)
Contingencies (Details)
Quarterly Financial Data (unaudited) (Details)
Subsequent Events (Details)
All Reports